20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Synthesis Strategies for (R)-Methyl Oxirane-2-Carboxylate: An Industrial Perspective

The efficient and enantioselective synthesis of chiral molecules is a cornerstone of modern chemical manufacturing. For (R)-Methyl Oxirane-2-Carboxylate (CAS: 111058-32-3), a critical intermediate for pharmaceuticals and fine chemicals, understanding its industrial synthesis pathways is crucial. NINGBO INNO PHARMCHEM CO.,LTD., a leading manufacturer in China, specializes in producing this compound with high purity and excellent stereochemical control. This article delves into the primary synthesis strategies, offering insights for R&D scientists and procurement professionals looking to buy this vital chemical.

Two main approaches dominate the industrial synthesis of enantiomerically pure epoxides like (R)-Methyl Oxirane-2-Carboxylate: asymmetric epoxidation and kinetic resolution. Each method offers distinct advantages and challenges, influencing process scalability, cost-effectiveness, and final product purity.

Asymmetric Epoxidation: Direct Creation of Chirality

Asymmetric epoxidation is a powerful strategy that directly creates the chiral center during the epoxide formation. This typically involves the stereoselective epoxidation of an achiral precursor, such as methyl acrylate. Various catalytic systems have been developed for this purpose, often employing chiral ligands bound to metal centers. For instance, transition metal complexes, particularly those involving metals like titanium, vanadium, or cobalt, in conjunction with chiral ligands (e.g., derivatives of tartaric acid or BINOL), can direct the oxygen atom to one face of the double bond, yielding the desired enantiomer with high selectivity.

Recent advancements also include the use of organocatalysts, which offer an metal-free alternative and can sometimes provide excellent enantioselectivities. The industrial implementation of these methods requires careful optimization of catalyst loading, reaction temperature, solvent choice, and oxidant (often peroxides). Achieving high enantiomeric excess (ee) is paramount, as it directly impacts the quality and suitability of the final product for pharmaceutical applications. As a dedicated manufacturer, we continuously refine these processes to maximize yield and enantioselectivity.

Kinetic Resolution: Separating Enantiomers

An alternative, widely used approach is kinetic resolution, which starts with a racemic mixture of the epoxide and selectively reacts with one enantiomer, leaving the desired enantiomer behind. This often involves enzymatic catalysis, where lipases or esterases are employed to selectively hydrolyze or acylate one enantiomer. For example, a lipase can be used to selectively hydrolyze the ester group of (S)-Methyl Oxirane-2-Carboxylate from a racemic mixture, allowing the unreacted (R)-enantiomer to be isolated. This method requires a readily available racemic starting material and an efficient, stereoselective resolving agent.

Another variant is chemo-enzymatic kinetic resolution, which combines chemical and enzymatic steps. While kinetic resolution can be highly effective in achieving high enantiomeric purity, the theoretical maximum yield for a classical kinetic resolution is 50%. Therefore, process optimization focuses on efficient separation and recycling of the resolving agent or exploring dynamic kinetic resolution (DKR) strategies that can achieve yields exceeding 50% by in-situ racemizing the undesired enantiomer.

Industrial Considerations and Supply from China

For industrial-scale production of (R)-Methyl Oxirane-2-Carboxylate, factors such as reagent cost, catalyst recyclability, waste generation, and ease of downstream processing are critical. Our operations as a leading China supplier focus on developing scalable and cost-effective synthesis routes that adhere to stringent quality standards. We understand that reliable access to high-purity chiral intermediates is essential for our clients' success.

If your organization requires a dependable source for (R)-Methyl Oxirane-2-Carboxylate, we encourage you to contact us for a quote. We are committed to providing competitive pricing and consistent product quality to meet your production needs.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Expert Sourcing: Why (R)-Methyl Oxirane-2-Carboxylate is Your Go-To Chemical Intermediate

Next: Unlocking Potency: Applications of (R)-Methyl Oxirane-2-Carboxylate in Drug Discovery

All Rights Reserved